# Exploring the Anti-ageing Effects of Metformin in COPD

> **NCT06999343** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Fundación Instituto de Investigación Sanitaria de Navarra** · enrollment: 212 (estimated)

## Conditions studied

- COPD

## Interventions

- **DRUG:** Metformin 850Mg Tab
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06999343
- **Lead sponsor:** Fundación Instituto de Investigación Sanitaria de Navarra
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2029-05-01
- **Final completion:** 2029-09-01
- **Target enrollment:** 212 (ESTIMATED)
- **Last updated:** 2025-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06999343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06999343, "Exploring the Anti-ageing Effects of Metformin in COPD". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT06999343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*